SB-220025 trihydrochloride

• CAT Number: I036051
• CAS Number: 197446-75-6
• Molecular Formula: C18H22Cl3FN6
• Molecular Weight: 447.7644
• Purity: 98%
• Synonyms: SB 220025 ; SB220025; SB-220025 trihydrochloride
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 5-(2-Aminopyrimidin-4-yl)-4-(4-fluorophenyl)-1-(4-piperidinyl)imidazole trihydrochloride
• InChI: InChI=1S/C18H19FN6.3ClH/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14;;;/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24);3*1H
• InChIKey: IPFBHUGKKONHFR-UHFFFAOYSA-N
• SMILES: FC1=CC=C(C2=C(C3=NC(N)=NC=C3)N(C4CCNCC4)C=N2)C=C1.[H]Cl.[H]Cl.[H]Cl

SB-220025 trihydrochloride (Cat.No:I036051) is a potent, specific inhibitor of human p38 mitogen-activated protein (MAP) kinase.

Reference

1: Bell CE, Watson AJ. p38 MAPK regulates cavitation and tight junction function in the mouse blastocyst. PLoS One. 2013 Apr 4;8(4):e59528. doi: 10.1371/journal.pone.0059528. Print 2013. PubMed PMID: 23593143; PubMed Central PMCID: PMC3617173.
2: Kanaji N, Nelson A, Allen-Gipson DS, Sato T, Nakanishi M, Wang X, Li Y, Basma H, Michalski J, Farid M, Rennard SI, Liu X. The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair. Inflamm Res. 2012 Mar;61(3):233-44. doi: 10.1007/s00011-011-0405-7. Epub 2011 Dec 3. PubMed PMID: 22138711.
3: Campbell JS, Argast GM, Yuen SY, Hayes B, Fausto N. Inactivation of p38 MAPK during liver regeneration. Int J Biochem Cell Biol. 2011 Feb;43(2):180-8. doi: 10.1016/j.biocel.2010.08.002. Epub 2010 Aug 11. PubMed PMID: 20708092; PubMed Central PMCID: PMC3022113.
4: Sharma A, Guan H, Yang K. The p38 mitogen-activated protein kinase regulates 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) expression in human trophoblast cells through modulation of 11beta-HSD2 messenger ribonucleic acid stability. Endocrinology. 2009 Sep;150(9):4278-86. doi: 10.1210/en.2009-0479. Epub 2009 Jun 4. PubMed PMID: 19497972.
5: Watanabe J, Natsume T, Kobayashi M. The inhibitory effect of docetaxel and p38 MAPK inhibitor on TZT-1027 (Soblidotin)-induced antivascular activity. Anticancer Res. 2007 Nov-Dec;27(6B):3909-18. PubMed PMID: 18225550.
6: Ishii T, Sootome H, Toyoda H, Suda M, Noumi T, Yamashita K. Dual enzyme-linked immunosorbent assay system for detection of endogenous kinase activities of mitogen- and stress-activated protein kinase-1/2. Assay Drug Dev Technol. 2007 Aug;5(4):523-33. PubMed PMID: 17767420.
7: Winger QA, Guttormsen J, Gavin H, Bhushan F. Heat shock protein 1 and the mitogen-activated protein kinase 14 pathway are important for mouse trophoblast stem cell differentiation. Biol Reprod. 2007 May;76(5):884-91. Epub 2007 Jan 31. PubMed PMID: 17267699.
8: Lahti A, Sareila O, Kankaanranta H, Moilanen E. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression. BMC Pharmacol. 2006 Feb 21;6:5. PubMed PMID: 16504051; PubMed Central PMCID: PMC1402273.
9: Madan P, Calder MD, Watson AJ. Mitogen-activated protein kinase (MAPK) blockade of bovine preimplantation embryogenesis requires inhibition of both p38 and extracellular signal-regulated kinase (ERK) pathways. Reproduction. 2005 Jul;130(1):41-51. PubMed PMID: 15985630.
10: Jacob T, Ascher E, Alapat D, Olevskaia Y, Hingorani A. Activation of p38MAPK signaling cascade in a VSMC injury model: role of p38MAPK inhibitors in limiting VSMC proliferation. Eur J Vasc Endovasc Surg. 2005 May;29(5):470-8. PubMed PMID: 15966085.
11: Paliga AJ, Natale DR, Watson AJ. p38 mitogen-activated protein kinase (MAPK) first regulates filamentous actin at the 8-16-cell stage during preimplantation development. Biol Cell. 2005 Aug;97(8):629-40. PubMed PMID: 15850458.
12: Nordin H, Jungnelius M, Karlsson R, Karlsson OP. Kinetic studies of small molecule interactions with protein kinases using biosensor technology. Anal Biochem. 2005 May 15;340(2):359-68. PubMed PMID: 15840510.
13: Seow CJ, Chue SC, Duan W, Yeo KS, Koh AH, Wong WS. Effects of inhibitors of the tyrosine signalling cascade on antigen challenge of guinea pig airways in vitro. Ann Acad Med Singapore. 2004 Sep;33(5 Suppl):S41-3. PubMed PMID: 15651201.
14: Chue SC, Seow CJ, Duan W, Yeo KS, Koh AH, Wong WS. Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro. Int Immunopharmacol. 2004 Aug;4(8):1089-98. PubMed PMID: 15222984.
15: Natale DR, Paliga AJ, Beier F, D’Souza SJ, Watson AJ. p38 MAPK signaling during murine preimplantation development. Dev Biol. 2004 Apr 1;268(1):76-88. PubMed PMID: 15031106.
16: Murray HJ, O’Connor JJ. A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro. Neuropharmacology. 2003 Mar;44(3):374-80. PubMed PMID: 12604095.
17: Jiang L, Jha V, Dhanabal M, Sukhatme VP, Alper SL. Intracellular Ca(2+) signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin. Am J Physiol Cell Physiol. 2001 May;280(5):C1140-50. PubMed PMID: 11287327.
18: Casanovas O, Miró F, Estanyol JM, Itarte E, Agell N, Bachs O. Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J Biol Chem. 2000 Nov 10;275(45):35091-7. PubMed PMID: 10952989.
19: Wang Z, Canagarajah BJ, Boehm JC, Kassisà S, Cobb MH, Young PR, Abdel-Meguid S, Adams JL, Goldsmith EJ. Structural basis of inhibitor selectivity in MAP kinases. Structure. 1998 Sep 15;6(9):1117-28. PubMed PMID: 9753691.
20: Jackson JR, Bolognese B, Hillegass L, Kassis S, Adams J, Griswold DE, Winkler JD. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther. 1998 Feb;284(2):687-92. PubMed PMID: 9454815.